NMN and Rapamycin Interaction

Compatible
Researched 90% confidence

NMN and Rapamycin have a compatible interaction with 90% confidence. Rapamycin (mTOR inhibitor) and NMN (NAD+ precursor) target distinct but complementary aging pathways. Rapamycin modulates mTOR-driven growth signaling while NMN supports NAD+-dependent repair and energy metabolism. No known negative interactions. Some longevity researchers use both as part of comprehensive anti-aging protocols. These compounds primarily affect different organ systems.

Compound Profiles

NMN

NAD+ Precursor | Cellular Energy & Longevity

NMN is converted to NAD+ via the NAD+ salvage pathway. After oral ingestion, NMN is absorbed in the gut, where it may be partially converted to nicotinamide riboside (NR) by the enzyme CD73 for cellular uptake, then re-phosphorylated intracellularly back to NMN.

Half-life: ~2-3 hours (oral) Typical dose: 250-1000 mg/day longevity, metabolic
carcinogenic riskteratogenic
View full profile

Rapamycin

mTOR Inhibitor | Longevity & Immunosuppression

Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.

Half-life: ~62 hours Typical dose: 3-6 mg once weekly (longevity protocol) longevity, immune
mtor immunosuppressiveinsulin disruptinglipid disruptingteratogenic
View full profile

Combined Organ Load

Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (NMN, Rapamycin). Monitor accordingly.

Frequently Asked Questions

Can I take NMN with Rapamycin?

Yes, NMN and Rapamycin can generally be taken together. Rapamycin (mTOR inhibitor) and NMN (NAD+ precursor) target distinct but complementary aging pathways. Rapamycin modulates mTOR-driven growth signaling while NMN supports NAD+-dependent repair and energy metabolism. No known negative interactions. Some longevity researchers use both as part of comprehensive anti-aging protocols.

Is NMN and Rapamycin safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between NMN and Rapamycin?

Rapamycin (mTOR inhibitor) and NMN (NAD+ precursor) target distinct but complementary aging pathways. Rapamycin modulates mTOR-driven growth signaling while NMN supports NAD+-dependent repair and energy metabolism. No known negative interactions. Some longevity researchers use both as part of comprehensive anti-aging protocols. This assessment has 90% confidence and is based on documented research data.

How should I time NMN and Rapamycin?

NMN has a half-life of ~2-3 hours (oral) and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: NMN vs Rapamycin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.